The influence of lymphadenectomy on the prognosis of small intestinal stromal tumors: a study based on the SEER database-Reference-Cited by-同舟云学术

The influence of lymphadenectomy on the prognosis of small intestinal stromal tumors: a study based on the SEER database

Published:2024-05-31 Issue:7 Volume:38 Page:3838-3848
ISSN:0930-2794
Container-title:Surgical Endoscopy
language:en
Short-container-title:Surg Endosc

Author:

Liu Luojie,Zhu Zhaoji,Zhou Jingjie,Ye Ye,Xu Liansheng,Xu Xiaodan

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00464-024-10906-8.pdf

Reference22 articles.

1. Lok KH, Lai L, Yiu HL et al (2009) Endosonographic surveillance of small gastrointestinal tumors originating from muscularis propria. J Gastrointestin Liver Dis 18(2):177–180

2. Nilsson B, Bümming P, Meis-Kindblom JM et al (2005) Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era–a population-based study in western Sweden. Cancer 103(4):821–829. https://doi.org/10.1002/cncr.20862

3. Tran T, Davila JA, El-Serag HB (2005) The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1458 cases from 1992 to 2000. Am J Gastroenterol 100(1):162–168. https://doi.org/10.1111/j.1572-0241.2005.40709.x

4. Almaazmi H, Stem M, Lo BD et al (2020) The impact of imatinib on survival and treatment trends for small bowel and colorectal gastrointestinal stromal tumors. J Gastrointest Surg 24(1):98–108. https://doi.org/10.1007/s11605-019-04344-4

5. Pantaleo MA, Nannini M, Di Battista M et al (2010) Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy. Cancer Treat Rev 36(1):63–68. https://doi.org/10.1016/j.ctrv.2009.10.004